Skip to main navigation
Skip to search
Skip to main content
UK Health Security Agency Main
Search content at UK Health Security Agency
Main
Profiles
Research units
Projects
Research output
Prizes
Activities
Impacts
Antibody response to SARS-CoV-2 infection in humans: A systematic review
Nathan Post
, Danielle Eddy
, Catherine Huntley
, May C.I. van Schalkwyk
, Madhumita Shrotri
, David Leeman
, Samuel Rigby
, Sarah V. Williams
, William H. Bermingham
, Paul Kellam
, John Maher
, Adrian M. Shields
,
Gayatri Amirthalingam
, Sharon Peacock
, Sharif A. Ismail
*
*
Corresponding author for this work
Immunisation & Vaccine Preventable Diseases
Research output
:
Contribution to journal
›
Article
›
peer-review
305
Citations (Scopus)
10
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antibody response to SARS-CoV-2 infection in humans: A systematic review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antibody Response
100%
SARS-CoV-2 Infection
100%
Neutralizing Antibodies
66%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
50%
Titre
33%
Disease Onset
33%
Acute Phase
33%
Convalescent Plasma
33%
Antibody Dynamics
33%
Symptom Onset
33%
Public Health
16%
Cross-reactivity
16%
Mild Infection
16%
Methodological Limitations
16%
COVID-19
16%
Asymptomatic Infection
16%
Serosurveillance
16%
Statistical Analysis
16%
Hospitalized Patients
16%
MEDLINE
16%
Embase
16%
Cross-neutralization
16%
Protective Immunity
16%
Disease Severity
16%
Demographic Characteristics
16%
Humoral Immune Response
16%
Mild Disease
16%
Serological Assay
16%
Novel Pathogen
16%
Disease Control Policy
16%
National Cohort Study
16%
Comprehensive Evaluation
16%
Self-reported Outcomes
16%
Arbitration
16%
Area of Uncertainty
16%
Recovery Phase
16%
Public Health Evidence
16%
Plateaued
16%
Long-term Patterns
16%
Severe Acute Respiratory Syndrome 2
16%
Immediate Recovery
16%
Multi-tool
16%
Quality Appraisal
16%
Coronaviridae
16%
Clinical Classification
16%
Method Research
16%
Immunology and Microbiology
Antibody Response
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Infectious Disease
100%
Infection
100%
Neutralizing Antibody
66%
Blood Plasma
33%
Cross-Reactivity
16%
Antibody Titer
16%
Humoral Immunity
16%
Infectious Agent
16%
Immunoglobulin M
16%
COVID-19
16%
Neutralization
16%
Severe Acute Respiratory Syndrome
16%
DNA Template
16%
Embase
16%
Coronaviridae
16%
Animal Experiment
16%
Clinical Classification
16%